ZURICH, Dec 23 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Tuesday:
COMPANY STATEMENTS CPR-CH
* Actelion ATLN.VX said it had submitted a new drug
application to the U.S. Food and Drug Administration, seeking
approval for selexipag for the treatment of patients with
pulmonary arterial hypertension. ATLN.VX
* Oerlikon OERL.S said it had agreed to sell its Advanced
Technologies Segment to Evatec AG. Both parties have agreed not
to disclose the purchase price, the company said. OERL.S
* Kudelski KUD.S said it had strengthened its
collaboration with upc cablecom in Switzerland. KUD.S
* EEII EIC.S named Andres Heusser as its new chief
executive. Heusser will assume the role on Jan. 1. EIC.S
* Goldbach Group GBMN.S said it had agreed to sell its 67
percent stake in Wilmaa to its founder Thomas Gabathuler.
GBMN.S
ECONOMY M-CH
((Zurich newsroom +41 58 306 7340, fax 41 44 251 0476,
zurich.newsroom@news.reuters.com))